-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
PharmaCyte Biotech, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2011 to 2023.
- PharmaCyte Biotech, Inc. Operating Income (Loss) for the quarter ending July 31, 2024 was -$1.27M, a 38.9% increase year-over-year.
- PharmaCyte Biotech, Inc. Operating Income (Loss) for the twelve months ending July 31, 2024 was -$7.71M, a 12.6% decline year-over-year.
- PharmaCyte Biotech, Inc. annual Operating Income (Loss) for 2023 was -$8.52M, a 32% decline from 2022.
- PharmaCyte Biotech, Inc. annual Operating Income (Loss) for 2022 was -$6.46M, a 47% decline from 2021.
- PharmaCyte Biotech, Inc. annual Operating Income (Loss) for 2021 was -$4.39M, a 21.2% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)